Clinical Trial Update: VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial [Phase 2]

View source ↗

Summary

A Phase 2 multicenter prospective single-arm trial evaluating the VA-CIG regimen as first-line treatment for previously untreated acute myeloid leukemia is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VA-CIG regimen

Snippet

Sponsor: Beijing 302 Hospital | Conditions: AML (Acute Myeloid Leukemia) | Phase 2 | Status: RECRUITING